HealthTech Capital Leads Investment in Cadence Biomedical

LOS ALTOS HILLS, Calif., Jan. 19, 2012 /PRNewswire/ -- HealthTech Capital announced today that it invested over $300,000 as the lead Series A2 investor in Cadence Biomedical, Inc. The move underscores the growing trend of angel investor groups joining forces to fund innovative, early-stage companies. Other investors included Alliance of Angels, Frontier Angels, Keiretsu Forum Northwest, Sand Hill Angels, and Wings. With a first close of ~$750,000 in new funds and note conversions, additional investors are expected to push the total to $1 million or more.


The funding supports the market launch of Cadence's novel device that helps people with severe disabilities walk. Worn externally, the device provides stability and movement assistance to weakened muscles without the use of powered mechanisms.
"With healthcare costs continuing their relentless march upward, creative technologies that decrease costs while improving patient care are attractive investment opportunities," said Don Ross, cofounder and managing director of HealthTech Capital. "Cadence is well positioned in the emerging HealthTech sector, and we are delighted to support such innovation with both investment dollars and hands-on mentoring."


"We are pleased to have HealthTech Capital as our lead investor," said Brian Glaister, Chief Executive Officer of Cadence. "Their domain expertise and professionalism are exceptional. They have worked with us and provide great added-value beyond their investment. With their lead, we are receiving the funding we need to bring our products to market."
"Cadence has the potential to change people's lives. When I tried the prototype, I could walk better immediately," said Donna Jang, Cadence Board Director and HealthTech Capital investor. "The experience was unlike any other in the 20 years since my stroke."


The Cadence device amplifies muscle strength, helping to propel the user forward and lift the leg and foot in preparation for the next step. Not only does it improve walking, it also has the potential to enable many who would otherwise require wheelchairs to regain strength and coordination.


About HealthTech Capital
HealthTech Capital is a leading Silicon Valley-based angel investing group that is pioneering the emerging HealthTech market where innovation improves healthcare delivery, empowers patients, and lowers costs. Founded by Anne DeGheest, Kathy La Porte, and Don Ross, HealthTech Capital has built a membership of industry leaders – successful entrepreneurs, executives, physicians, and venture capitalists – who fund and mentor new companies. For more information, please visit www.HealthTechCapital.com.

About Cadence Biomedical
Cadence Biomedical is a privately held early stage medical device company whose mission is to improve mobility for people with disabilities. The company's flagship kinetic orthosis product is a revolutionary device that can provide assistance to muscles and help people with severe disabilities walk. Cadence is headquartered in Seattle, WA. For more information, please visit www.cadencebiomedical.com.

EVENTS

05 June 2018 CIMED Israeli Medtech and Healthtech

Anne DeGheest will be a judge at Cimed on June 19, 2018 in Menlo Park. Come join me to see exciting new medical devices and HealthTech companies coming from Israel. Use code Medstar40 for 40% discount

05 June 2018 Boomer Summit June 20-21, 2018

Anne DeGheest will be on a panel at the Boomer summit in Berkeley on june 20 and 21, 2018.

@HealthTechCap is a proud sponsor of the Silicon Valley @SiliconBoomer Summit 6/20-21.

Use code sv18healthtech20 more at https://lnkd.in/eeJVJmu https://lnkd.in/eMHmrD7

17 March 2018 Boomer summit March 27-28, 2018

I’ll be one of the featured speakers at the What’s Next #Boomer Summit in San Francisco, CA. March 27-28 in San Francisco Use my 20% discount code: WH18FOM

04 March 2018 HAAS Healthcare Conference 2018

When: March 9, 2018 from 3 to 3:50pm

Location: SF Mission Bay Conference Center

  • 1675 Owens Street #251, San Francisco, CA, 94158

Panel: Consumerization 2.0

  • Anne DeGheest (our moderator) - Founder and Managing Director at HealthTech Capital and Medstars
  • Naomi Kelman - President and CEO at Willow,
  • Dr. Cameron Sepah - Founder and CEO at Actualize and Entrepreneur in Residence at Trinity Ventures, 
  • Adam Kovalevsky - SVP Product, Engineering, and Design at Collective Health 
  • Yasi Baiani - Head of Product Management, Software Experiences, Fitbit


RSS

© 2011 HealthTech Capital. All Rights Reserved. Designed by Night River